Alex Adjei
Chair, Taussig Cancer Institute, Cleveland Clinic · Case Western Reserve University
Credentials: · · · · ·
History
- Present
Taussig Cancer Institute Center · Case Western Reserve University
PresentCancer Institute Division · Cleveland Clinic Foundation
- 1993–1995
Johns Hopkins University School of Medicine and Hospital
- 1982–1983
- 1978–1982
- 1973–1977
Research
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship
Review · Mayo Clinic Proceedings · 2008 · Last of 5 authors · 2,750 citations
Targeting apoptosis pathways in cancer therapy
Review · Current Anthropology · 2005 · Last of 3 authors · 1,052 citations
Blocking oncogenic Ras signaling for cancer therapy
Review · Journal of the National Cancer Institute · 2001 · Sole author · 700 citations
55 papers · 19 as a resident
39 papers
32 papers · 1 as a fellow
32 papers
- SS
26 papers
25 papers · 1 as a fellow
- JJ
22 papers
- HP
19 papers
Grants
- 1997–2024
Mayo Clinic Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $1.2M · Mayo Clinic Rochester
- 2014–2022
NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis
National Cancer Institute · UM1
Contact PI · $4.3M · Mayo Clinic Rochester
- 2018–2021
Clinical Evaluation of Combination Oncolytic Viro-Immunotherapy for Solid Tumors
National Cancer Institute · R44
PI · $1.2M · Vyriad, Inc.
- 2014–2019
Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.
National Cancer Institute · U10
PI · $1.1M · Roswell Park Cancer Institute Corp
Clinical trials
- 2019–2025
Principal investigator · Active not recruiting · Phase 1, Phase 2
Vyriad, Inc.
- 2018–2020
Principal investigator · Terminated · Phase 1
Mayo Clinic
- 2018–2022
Principal investigator · Completed · Phase 1
Mayo Clinic
- 2015
Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
Principal investigator · Withdrawn · Phase 1
Roswell Park Cancer Institute